Dr. Erin Blake is a gynecological oncologist at c-Care in northeast Fresno. She explains that it's often hard to detect ovarian cancer in its early stages. "There's no effective screening for ovarian ...

Daiichi and Merck saw the highest ORR—57.1%—in patients who received the top dose of R-DXd. Yet the drugmakers have opted to take the middle 5.6 mg/kg dose into the phase 3 part of the trial. The ORR ...

B ERLIN -- After multiple failed attempts, an immune checkpoint inhibitor has broken through and landed a significant overall ...